Form 8-K - Current report:
SEC Accession No. 0001193125-21-259349
Filing Date
2021-08-27
Accepted
2021-08-27 16:10:57
Documents
12
Period of Report
2021-08-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d184220d8k.htm   iXBRL 8-K 20635
  Complete submission text file 0001193125-21-259349.txt   142620

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arwr-20210823.xsd EX-101.SCH 2919
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20210823_lab.xml EX-101.LAB 18139
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20210823_pre.xml EX-101.PRE 11426
5 EXTRACTED XBRL INSTANCE DOCUMENT d184220d8k_htm.xml XML 3367
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38042 | Film No.: 211219022
SIC: 2834 Pharmaceutical Preparations